Jan van Lunzen

11.8k total citations · 1 hit paper
145 papers, 6.2k citations indexed

About

Jan van Lunzen is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Jan van Lunzen has authored 145 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Virology, 70 papers in Infectious Diseases and 43 papers in Immunology. Recurrent topics in Jan van Lunzen's work include HIV Research and Treatment (104 papers), HIV/AIDS Research and Interventions (52 papers) and HIV/AIDS drug development and treatment (48 papers). Jan van Lunzen is often cited by papers focused on HIV Research and Treatment (104 papers), HIV/AIDS Research and Interventions (52 papers) and HIV/AIDS drug development and treatment (48 papers). Jan van Lunzen collaborates with scholars based in Germany, United States and United Kingdom. Jan van Lunzen's co-authors include Marcus Altfeld, Hans‐Jürgen Stellbrink, Paul Rácz, Julian Schulze zur Wiesch, Hans‐Juergen Stellbrink, Klara Tenner‐Racz, Bonaventura Clotet, Roberto Ortiz, Gerd Fätkenheuer and Jörn E. Schmitz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Jan van Lunzen

143 papers receiving 6.0k citations

Hit Papers

Once-daily dolutegravir versus darunavir plus ritonavir i... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
    2014 350 citations Jan van Lunzen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan van Lunzen Germany 42 3.7k 3.1k 2.0k 1.3k 759 145 6.2k
Cécile Goujard France 49 5.0k 1.3× 4.0k 1.3× 2.8k 1.4× 2.0k 1.6× 1.0k 1.3× 230 8.2k
Hernán Valdez United States 43 2.3k 0.6× 1.7k 0.6× 2.5k 1.2× 1.4k 1.1× 498 0.7× 154 7.1k
Giuseppe Tambussi Italy 42 2.7k 0.7× 1.9k 0.6× 2.7k 1.4× 1.0k 0.8× 688 0.9× 149 5.3k
Luis J. Montaner United States 46 3.1k 0.8× 2.1k 0.7× 3.7k 1.9× 1.3k 1.0× 422 0.6× 190 6.9k
James O. Kahn United States 36 3.5k 0.9× 3.6k 1.2× 1.3k 0.7× 1.7k 1.3× 487 0.6× 70 5.8k
Laurence Weiss France 42 2.5k 0.7× 1.9k 0.6× 2.7k 1.3× 1.3k 1.0× 643 0.8× 140 5.6k
Maria Carla Re Italy 35 1.9k 0.5× 1.5k 0.5× 1.1k 0.6× 1.2k 0.9× 751 1.0× 258 4.6k
Colin Kovacs Canada 42 3.5k 0.9× 2.3k 0.8× 2.3k 1.2× 1.0k 0.8× 604 0.8× 111 5.3k
Audrey Kinter United States 35 4.6k 1.2× 1.9k 0.6× 4.3k 2.2× 1.5k 1.2× 481 0.6× 47 6.9k
Michael A. Polis United States 43 4.3k 1.2× 3.5k 1.1× 2.8k 1.4× 2.9k 2.3× 832 1.1× 143 8.6k

Countries citing papers authored by Jan van Lunzen

Since Specialization
Citations

This map shows the geographic impact of Jan van Lunzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan van Lunzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan van Lunzen more than expected).

Fields of papers citing papers by Jan van Lunzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan van Lunzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan van Lunzen. The network helps show where Jan van Lunzen may publish in the future.

Co-authorship network of co-authors of Jan van Lunzen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan van Lunzen. A scholar is included among the top collaborators of Jan van Lunzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan van Lunzen. Jan van Lunzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Xun, Manoj Kumar Gupta, Jéssica Cristina dos Santos, et al.. (2024). Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands. Frontiers in Immunology. 15. 1459593–1459593.
2.
3.
Mast, Quirijn de, Marc J. T. Blaauw, W Vos, et al.. (2024). Plasma proteomic signatures of liver steatosis and fibrosis in people living with HIV: a cross-sectional study. EBioMedicine. 109. 105407–105407. 3 indexed citations
4.
Vos, W, Marc J. T. Blaauw, Vasiliki Matzaraki, et al.. (2024). HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity. Frontiers in Immunology. 15. 1350065–1350065. 7 indexed citations
5.
Heijden, Wouter A. van der, Lisa Van de Wijer, Farid Keramati, et al.. (2021). Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells. JCI Insight. 6(7). 45 indexed citations
6.
Ahmad, Fareed, Heiner Wedemeyer, Markus Cornberg, et al.. (2016). Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype. Virology Journal. 13(1). 8 indexed citations
7.
Geißler, René, Ilona Hauber, Jan Chemnitz, et al.. (2015). Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study. Virology. 486. 248–254. 5 indexed citations
8.
Dammermann, Werner, Lars Komorowski, Katja Steinhagen, et al.. (2014). CMV specific cytokine release assay in whole blood is optimized by combining synthetic CMV peptides and toll like receptor agonists. Journal of Immunological Methods. 414. 82–90. 11 indexed citations
9.
Rodger, Alison, Tina Bruun, Matthew Weait, et al.. (2012). Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods. BMC Public Health. 12(1). 296–296. 26 indexed citations
10.
Lindqvist, Madelene, Jan van Lunzen, Damien Z. Soghoian, et al.. (2012). Expansion of HIV-specific T follicular helper cells in chronic HIV infection. Journal of Clinical Investigation. 122(9). 3271–3280. 321 indexed citations
11.
Wyen, Christoph, Björn‐Erik Ole Jensen, Marcus Hentrich, et al.. (2011). Treatment of AIDS-related lymphomas. AIDS. 26(4). 457–464. 22 indexed citations
12.
Lehmann, Clara, Dirk Taubert, Norma Jung, et al.. (2009). Preferential Upregulation of Interferon-α Subtype 2 Expression in HIV-1 Patients. AIDS Research and Human Retroviruses. 25(6). 577–581. 29 indexed citations
13.
Zoufaly, Alexander, Christina Kreuzberg, Matthias an der Heiden, et al.. (2008). O423 Risk of new AIDS-defining events in patients with advanced immunodeficiency during suppressive HAART: results from the German ClinSurv cohort. Journal of the International AIDS Society. 11(Suppl 1). O45–O45. 1 indexed citations
14.
Meier, Angela, Galit Alter, Nicole Frahm, et al.. (2007). MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands. Journal of Virology. 81(15). 8180–8191. 197 indexed citations
15.
Kowalska, Justyna, Amanda Mocroft, Anders Blaxhult, et al.. (2007). Current Hemoglobin Levels Are More Predictive of Disease Progression Than Hemoglobin Measured at Baseline in Patients Receiving Antiretroviral Treatment for HIV Type 1 Infection. AIDS Research and Human Retroviruses. 23(10). 1183–1188. 11 indexed citations
16.
Bánki, Zoltán, Doris Wilflingseder, Christoph G. Ammann, et al.. (2006). Factor I-Mediated Processing of Complement Fragments on HIV Immune Complexes Targets HIV to CR2-Expressing B Cells and Facilitates B Cell-Mediated Transmission of Opsonized HIV to T Cells. The Journal of Immunology. 177(5). 3469–3476. 31 indexed citations
17.
Lunzen, Jan van. (2006). GENE THERAPY OF HIV INFECTION BY TRANSDUCED AUTOLOGOUS CD4 T-CELLS INHIBITING VIRAL ENTRY. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(3). S26–S27.
18.
Mocroft, Amanda, Andrew Phillips, Veronica Miller, et al.. (2001). The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study. AIDS. 15(2). 201–209. 50 indexed citations
19.
Lunzen, Jan van, et al.. (1995). Investigations on Autologous T-Cells for Adoptive Immunotherapy of Aids. Advances in experimental medicine and biology. 374. 57–70. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cécile Goujard Breakdown of academic impact, for papers by Hernán Valdez Breakdown of academic impact, for papers by Giuseppe Tambussi Breakdown of academic impact, for papers by Luis J. Montaner Breakdown of academic impact, for papers by James O. Kahn Breakdown of academic impact, for papers by Laurence Weiss Breakdown of academic impact, for papers by Maria Carla Re Breakdown of academic impact, for papers by Colin Kovacs Breakdown of academic impact, for papers by Audrey Kinter Breakdown of academic impact, for papers by Michael A. Polis
Rankless by CCL
2026